Cross-institution positioning
Apr 30, 2026Reduction leaning. 2 accumulating, 2 reducing, 1 exited across 5 comparable institutions.
Source: Schedule 13 researchSee how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Reduction leaning. 2 accumulating, 2 reducing, 1 exited across 5 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsRecent Forms 3/4/5 activity is available, with no non-amendment non-derivative SEC-coded P/S transactions in the rolling 90-day window. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/54 non-amendment material events in the last 90 days; Latest classified evidence: Other event. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue -6.9% YoY; Net income +13.1% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 8% through its reported 52-week range; -2.6% over one year.
Source: Stored historical price seriesFiled Apr 30, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | YARDLEY JAMES C | AGrant, award, or other acquisition · derivative | Phantom Shares | 160 | $78.05 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | Kirk Jennifer M | AGrant, award, or other acquisition · derivative | Phantom Shares | 160 | $78.05 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | Ferrero Pablo | AGrant, award, or other acquisition · derivative | Phantom Shares | 160 | $78.05 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | CONESA ANDRES | AGrant, award, or other acquisition · derivative | Phantom Shares | 160 | $78.05 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | MEARS MICHAEL N | AGrant, award, or other acquisition · derivative | Phantom Shares | 160 | $78.05 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | Taylor Jack T | AGrant, award, or other acquisition · derivative | Phantom Shares | 160 | $78.05 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | WARNER CYNTHIA J | AGrant, award, or other acquisition · derivative | Phantom Shares | 372 | $78.05 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | MARK RICHARD J | AGrant, award, or other acquisition · derivative | Phantom Shares | 160 | $78.05 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | Sagara Kevin C. | AGrant, award, or other acquisition · derivative | Phantom Shares | 160 | $78.05 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | Weaving Anya | AGrant, award, or other acquisition · derivative | Phantom Shares | 160 | $78.05 | Direct | Oct 2, 2026 |
| Jul 1, 2026 | YARDLEY JAMES C | AGrant, award, or other acquisition · derivative | Phantom Shares | 137 | $91.37 | Direct | Jul 2, 2026 |
| Jul 1, 2026 | Weaving Anya | AGrant, award, or other acquisition · derivative | Phantom Shares | 137 | $91.37 | Direct | Jul 2, 2026 |
| Jul 1, 2026 | WARNER CYNTHIA J | AGrant, award, or other acquisition · derivative | Phantom Shares | 317 | $91.37 | Direct | Jul 2, 2026 |
| Jul 1, 2026 | Taylor Jack T | AGrant, award, or other acquisition · derivative | Phantom Shares | 137 | $91.37 | Direct | Jul 2, 2026 |
| Jul 1, 2026 | Sagara Kevin C. | AGrant, award, or other acquisition · derivative | Phantom Shares | 137 | $91.37 | Direct | Jul 2, 2026 |
| Jul 1, 2026 | MEARS MICHAEL N | AGrant, award, or other acquisition · derivative | Phantom Shares | 137 | $91.37 | Direct | Jul 2, 2026 |
| Jul 1, 2026 | MARK RICHARD J | AGrant, award, or other acquisition · derivative | Phantom Shares | 137 | $91.37 | Direct | Jul 2, 2026 |
| Jul 1, 2026 | Kirk Jennifer M | AGrant, award, or other acquisition · derivative | Phantom Shares | 137 | $91.37 | Direct | Jul 2, 2026 |
| Jul 1, 2026 | Ferrero Pablo | AGrant, award, or other acquisition · derivative | Phantom Shares | 137 | $91.37 | Direct | Jul 2, 2026 |
| Jul 1, 2026 | CONESA ANDRES | AGrant, award, or other acquisition · derivative | Phantom Shares | 137 | $91.37 | Direct | Jul 2, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Aug 21, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Aug 18, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Aug 6, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jul 9, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Jun 16, 2026 | 8-K | 7.01 | Regulation FD disclosure | — | Filing |
| Jun 9, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Jun 5, 2026 | 424B2 | — | Prospectus filing | Capital-related | Filing |
| Jun 4, 2026 | 424B5 | — | Prospectus filing | Capital-related | Filing |
| May 15, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| May 15, 2026 | S-3ASR | — | Shelf securities registration | Capital-related | Filing |
| May 14, 2026 | 8-K | 5.07 | Shareholder vote results | — | Filing |
| May 12, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Mar 31, 2026 | $3.4B | -6.9% |
| Ended Sep 30, 2025 | $2.8B | +7.3% |
| Ended Jun 30, 2025 | $2.7B | +8.7% |
| Ended Mar 31, 2025 | $3.7B | -0.4% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $12.4B | +5.1% |
| Ended Dec 31, 2024 | $11.8B | -20.4% |
| Ended Dec 31, 2023 | $14.8B | +8.2% |
| Ended Dec 31, 2022 | $13.7B | +17.5% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 quarter end Aug 13, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 42.7M | $81.34 | |||
| Vanguard Capital Management CIK0002100119 | Mar 31, 2026 observed Apr 30, 2026 filed · 30d Initial Schedule 13G | Initial Schedule 13G | 49.3M | 12.00% | $97.17 | $95.12 | $81.34 |
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 27, 2026 filed · 14d Schedule 13G amendment | Reported reduction | 11 -75.7M | 12.00% +0.40 pts | $95.11 | $95.88 | $81.34 |
Compare SRE with other securities showing similar institutional activity or recent accumulation across several tracked institutions.